Clinical Perspectives on the Utility of Aromatase Inhibitors for the Adjuvant Treatment of Breast Cancer

Breast. 2009 Aug;18 Suppl 2:S1-11. doi: 10.1016/S0960-9776(09)70002-5.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Anastrozole
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Female
  • Humans
  • Letrozole
  • Middle Aged
  • Neoplasm Staging
  • Nitriles / therapeutic use
  • Postmenopause*
  • Secondary Prevention
  • Survival Analysis
  • Tamoxifen / therapeutic use
  • Triazoles / therapeutic use
  • Women's Health*

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Nitriles
  • Triazoles
  • Tamoxifen
  • Anastrozole
  • Letrozole